Search details
1.
IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance.
Nature
; 589(7843): 597-602, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33361818
2.
Retraction Note: IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance.
Nature
; 599(7885): 518, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34580487
3.
Clinical management of TP53 mosaic variants found on germline genetic testing.
Cancer Genet
; 284-285: 43-47, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38677009
4.
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers.
bioRxiv
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38617260
5.
Rates of Intervention and Cancer Detection on Initial versus Subsequent Whole-body MRI Screening in Li-Fraumeni Syndrome.
Cancer Prev Res (Phila)
; 16(9): 507-512, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37428016
6.
SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy.
medRxiv
; 2021 Jan 16.
Article
in English
| MEDLINE | ID: mdl-33469597
7.
SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy.
JCO Oncol Pract
; 17(12): e1879-e1886, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34133219
8.
Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser.
Elife
; 92020 11 10.
Article
in English
| MEDLINE | ID: mdl-33170774
9.
A Novel Inhibitor of HSP70 Induces Mitochondrial Toxicity and Immune Cell Recruitment in Tumors.
Cancer Res
; 80(23): 5270-5281, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-33023943
10.
Tailoring Chemotherapy for the African-Centric S47 Variant of TP53.
Cancer Res
; 78(19): 5694-5705, 2018 10 01.
Article
in English
| MEDLINE | ID: mdl-30115697
Results
1 -
10
de 10
1
Next >
>>